Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Open Forum Infect Dis ; 11(8): ofae416, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39100532

ABSTRACT

Background: Adherence to anti-tuberculosis treatment (ATT) in Brazil remains a challenge in achieving the goals set by the World Health Organization (WHO). Patients who are lost to follow-up during treatment pose a significant public health problem. This study aimed to investigate the factors associated with unfavorable ATT outcomes among those undergoing retreatment in Brazil. Methods: We conducted an observational study of patients aged ≥18 years with tuberculosis (TB) reported to the Brazilian National Notifiable Disease Information System between 2015 and 2022. Clinical and epidemiologic variables were compared between the study groups (new cases and retreatment). Regression models identified variables associated with unfavorable outcomes. Results: Among 743 823 reported TB cases in the study period, 555 632 cases were eligible, consisting of 462 061 new cases and 93 571 undergoing retreatments (44 642 recurrent and 48 929 retreatments after loss to follow-up [RLTFU]). RLTFU (odds ratio [OR], 3.96 [95% confidence interval {CI}, 3.83-4.1]) was a significant risk factor for any type of unfavorable ATT. Furthermore, RLTFU (OR, 4.93 [95% CI, 4.76-5.11]) was the main risk factor for subsequent LTFU. For death, aside from advanced age, living with HIV (OR, 6.28 [95% CI, 6.03-6.54]) was the top risk factor. Conclusions: Retreatment is a substantial risk factor for unfavorable ATT outcomes, especially after LTFU. The rates of treatment success in RLTFU are distant from the WHO End TB Strategy targets throughout Brazil. These findings underscore the need for targeted interventions to improve treatment adherence and outcomes in persons who experience RLTFU.

2.
Int J STD AIDS ; 35(11): 894-901, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39034657

ABSTRACT

INTRODUCTION: HIV has transitioned from a devastating 1980s epidemic to a manageable chronic condition with antiretroviral therapy. In Brazil, challenges persist, including high detection rates and loss of medical follow-up among people living with HIV/AIDS (PLHIV). Adherence, engagement, and avoiding loss to follow-up are critical for effective HIV/AIDS prevention and care. OBJECTIVES: This case-control study within longitudinal research on PLHIV linkage and retention in Porto Alegre aims to analyze factors associated with treatment abandonment. METHODS: The study, based on patients from the Therapeutic Care Service for HIV and AIDS at Sanatorio Partenon Hospital, involved 360 PLHIV in a retention and linkage outpatient clinic. RESULTS: Risk factors for loss to follow-up include cisgender women, diagnosis between 1991 and 2005, and non-adherence to antiretroviral treatment (ART). Conversely, cisgender men, diagnosis between 2015 and 2023, and good ART adherence were protective factors. CONCLUSION: Gender disparities and ART non-adherence pose significant challenges in comprehensive PLHIV care. Cisgender women diagnosed before 2005 face higher risk, while cisgender men diagnosed after 2015 with good ART adherence are more protected, influencing care and prevention strategies for PLHIV.


Subject(s)
Anti-HIV Agents , HIV Infections , Medication Adherence , Humans , Female , Case-Control Studies , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV Infections/prevention & control , Adult , Brazil/epidemiology , Medication Adherence/statistics & numerical data , Male , Anti-HIV Agents/therapeutic use , Middle Aged , Lost to Follow-Up , Risk Factors , Longitudinal Studies , Health Policy
3.
BMC Public Health ; 24(1): 1385, 2024 May 23.
Article in English | MEDLINE | ID: mdl-38783264

ABSTRACT

BACKGROUND: Identifying patients at increased risk of loss to follow-up (LTFU) is key to developing strategies to optimize the clinical management of tuberculosis (TB). The use of national registry data in prediction models may be a useful tool to inform healthcare workers about risk of LTFU. Here we developed a score to predict the risk of LTFU during anti-TB treatment (ATT) in a nationwide cohort of cases using clinical data reported to the Brazilian Notifiable Disease Information System (SINAN). METHODS: We performed a retrospective study of all TB cases reported to SINAN between 2015 and 2022; excluding children (< 18 years-old), vulnerable groups or drug-resistant TB. For the score, data before treatment initiation were used. We trained and internally validated three different prediction scoring systems, based on Logistic Regression, Random Forest, and Light Gradient Boosting. Before applying our models we splitted our data into training (~ 80% data) and test (~ 20%) sets, and then compared the model metrics using the test data set. RESULTS: Of the 243,726 cases included, 41,373 experienced LTFU whereas 202,353 were successfully treated. The groups were different with regards to several clinical and sociodemographic characteristics. The directly observed treatment (DOT) was unbalanced between the groups with lower prevalence in those who were LTFU. Three models were developed to predict LTFU using 8 features (prior TB, drug use, age, sex, HIV infection and schooling level) with different score composition approaches. Those prediction scoring systems exhibited an area under the curve (AUC) ranging between 0.71 and 0.72. The Light Gradient Boosting technique resulted in the best prediction performance, weighting specificity and sensitivity. A user-friendly web calculator app was developed ( https://tbprediction.herokuapp.com/ ) to facilitate implementation. CONCLUSIONS: Our nationwide risk score predicts the risk of LTFU during ATT in Brazilian adults prior to treatment commencement utilizing schooling level, sex, age, prior TB status, and substance use (drug, alcohol, and/or tobacco). This is a potential tool to assist in decision-making strategies to guide resource allocation, DOT indications, and improve TB treatment adherence.


Subject(s)
Lost to Follow-Up , Machine Learning , Registries , Tuberculosis , Humans , Male , Female , Retrospective Studies , Adult , Brazil/epidemiology , Middle Aged , Tuberculosis/drug therapy , Tuberculosis/epidemiology , Young Adult , Antitubercular Agents/therapeutic use , Adolescent , Algorithms
4.
AIDS Behav ; 28(7): 2403-2409, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38720109

ABSTRACT

Despite the effectiveness of antiretroviral therapy (ART), human immunodeficiency virus (HIV) infection remains a global public health concern. However, weaknesses in its management regarding access to integrated HIV care include treatment gaps and loss to follow-up (LTFU) from antiretroviral treatment (ART). This study aimed to characterize the epidemiological and clinical profiles of people living with HIV/AIDS (PLHA) in LTFU from HIV care in Campo Grande, Central Brazil. This retrospective cross-sectional study was conducted between January 2021 and April 2022 using secondary data from PLHA who had LTFU in Campo Grande. A total of 852 patients with PLHA were included in this study. The majority of participants in LTFU were male (63.1%), had a CD4 cell count > 200 cells/mm3 (68.2%), and had been treated for ≥ 3 months (86.4%). Only 287 (33.7%) participants had undetectable HIV viral load. Of the total number of patients who returned to treatment during the study period, 448 (54.3%) were LTFU-positive. The tracking strategy was not applied to 556 (65.26%) patients, and 44.4% of the participants had been in spontaneous demand. These results highlight the relevance of patient-centered interventions and the need to ensure early treatment and promote retention in care systems with consequent viral suppression, impacting the healthcare indicators of the population, with emphasis on health managers and stakeholders in HIV care.


Subject(s)
HIV Infections , Lost to Follow-Up , Viral Load , Humans , Male , Brazil/epidemiology , Female , Cross-Sectional Studies , Retrospective Studies , HIV Infections/drug therapy , HIV Infections/epidemiology , Adult , Middle Aged , CD4 Lymphocyte Count , Anti-HIV Agents/therapeutic use , Health Services Accessibility , Medication Adherence/statistics & numerical data
5.
J Pediatr ; 268: 113931, 2024 May.
Article in English | MEDLINE | ID: mdl-38311237

ABSTRACT

OBJECTIVE: To analyze receipt of care at other locations within a single rural academic health system after loss to follow-up in a cardiology clinic. STUDY DESIGN: Patients with congenital heart defects seen in the clinic during 2018 and subsequently lost to cardiology follow-up were included in the study. We defined loss to follow-up as not being seen in the clinic for at least 6 months past the most recently recommended follow-up visit. Subsequent visits to other locations, including other subspecialty clinics, primary care clinics, the emergency department, and the hospital, were tracked through 2020. RESULTS: Of 235 patients (median age 7 years, 136/99 female/male), 96 (41%) were seen elsewhere in the health system. Of 96 patients with any follow-up, 40 were seen by a primary care provider and 46 by another specialist; 44 were seen in the emergency department and 12 more were hospitalized. Patients with medical comorbidities or Medicaid insurance and those living closer to the clinic were more likely to continue receiving care within the same health system. CONCLUSIONS: Patients with congenital heart defect are frequently lost to cardiology follow-up. Our study supports collaboration across specialties and between cardiology clinics and affiliated emergency departments to identify patients with congenital heart defect who have been lost to cardiology follow-up but remain within the health system. A combination of in-person and remote outreach to these patients may help them continue cardiology care.


Subject(s)
Heart Defects, Congenital , Lost to Follow-Up , Humans , Heart Defects, Congenital/therapy , Female , Male , Child , Child, Preschool , Adolescent , Infant , Emergency Service, Hospital/statistics & numerical data , Retrospective Studies , Follow-Up Studies , Primary Health Care/statistics & numerical data , Cardiology
6.
SAGE Open Med ; 11: 20503121231199655, 2023.
Article in English | MEDLINE | ID: mdl-37808513

ABSTRACT

Objectives: To identify risk factors for loss to follow-up in periodic intravitreal anti-vascular endothelial growth factor injections for the treatment patients with diabetic macular edema, subretinal neovascularization, age-related macular degeneration, and retinal vein occlusion in a single eye center in São Paulo, Brazil. Methods: This was a retrospective longitudinal study that gathered information from 992 patients who required intravitreal anti-vascular endothelial growth factor drugs over 6 months. The authors included age, eye disease, laterality, monthly income, distance, and payment mode as risk factors. Results: Two hundred and seventy patients (29.93%) were lost to follow-up. Multivariate analysis showed age, monthly income, eye involvement, and type of medical assistance independently associated with loss to follow-up. The odds of loss to follow-up were greater among older patients than those less than 50 years (reference), p < 0.001. The odds of loss to follow-up were greater among patients who received unilateral treatment than those who received bilateral injections (p = 0.013). Concerning gross monthly income, there were no differences in the odds of the four salary strata; the data also indicate an absence of difference in the three strata of patients' distance to the clinic. Considering the diagnosis, only age-related macular degeneration showed greater odds of loss to follow-up (p = 0.016). Finally, the data suggest greater odds of loss to follow-up in private patients than in those on a health care plan (p < 0.001). Conclusion: Loss to follow-up is paramount because many patients may remain unassisted concerning their eye diseases. Identifying the risk factors is crucial to enforcing measures to increase adherence and the long-term success of the treatment.

7.
Clin Infect Dis ; 76(3): e930-e937, 2023 02 08.
Article in English | MEDLINE | ID: mdl-35788646

ABSTRACT

BACKGROUND: Successful tuberculosis (TB) treatment is necessary for disease control. The World Health Organization (WHO) has a target TB treatment success rate of ≥90%. We assessed whether the different types of unfavorable TB treatment outcome had different predictors. METHODS: Using data from Regional Prospective Observational Research for Tuberculosis-Brazil, we evaluated biological and behavioral factors associated with each component of unsuccessful TB outcomes, recently updated by WHO (death, loss to follow-up [LTFU], and treatment failure). We included culture-confirmed, drug-susceptible, pulmonary TB participants receiving standard treatment in 2015-2019. Multinomial logistic regression models with inverse probability weighting were used to evaluate the distinct determinants of each unsuccessful outcome. RESULTS: Of 915 participants included, 727 (79%) were successfully treated, 118 (13%) were LTFU, 44 (5%) had treatment failure, and 26 (3%) died. LTFU was associated with current drug-use (adjusted odds ratio [aOR] = 5.3; 95% confidence interval [CI], 3.0-9.4), current tobacco use (aOR = 2.9; 95% CI, 1.7-4.9), and being a person with HIV (PWH) (aOR = 2.0; 95% CI, 1.1-3.5). Treatment failure was associated with PWH (aOR = 2.7; 95% CI, 1.2-6.2) and having diabetes (aOR = 2.2; 95% CI, 1.1-4.4). Death was associated with anemia (aOR = 5.3; 95% CI, 1.4-19.7), diabetes (aOR = 3.1; 95% CI, 1.4-6.7), and PWH (aOR = 3.9; 95% CI, 1.3-11.4). Direct observed therapy was protective for treatment failure (aOR = 0.5; 95% CI, .3-.9) and death (aOR = 0.5; 95% CI, .2-1.0). CONCLUSIONS: The treatment success rate was below the WHO target. Behavioral factors were most associated with LTFU, whereas clinical comorbidities were correlated with treatment failure and death. Because determinants of unsuccessful outcomes are distinct, different intervention strategies may be needed to improve TB outcomes.


Subject(s)
Antitubercular Agents , Tuberculosis , Humans , Antitubercular Agents/therapeutic use , Brazil/epidemiology , Risk Factors , Tuberculosis/drug therapy , Tuberculosis/complications , Treatment Outcome , Retrospective Studies
8.
CoDAS ; 35(6): e20220114, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1506057

ABSTRACT

ABSTRACT Purpose Analyze maternal and child predictors associated with loss to follow-up in the newborn hearing screening program at maternity hospitals in northeastern Brazil. Methods Retrospective cohort study, including secondary data from infants (n=604) referred to the newborn hearing screening program in two maternity hospitals for monitoring and/or diagnosis. The predictors evaluated included socioeconomic factors, such as maternal age, marital status, income, schooling, place of residence, number of children and number of prenatal visits. In addition, maternal and child health factors, such as smoking and drug intake during pregnancy, consanguinity, congenital infections, craniofacial malformations, use of ototoxic drugs, syndromes and a history of hearing loss in the family. Statistical analysis was performed based on binary logistic regression models, using the stepwise method. Results The logistic regression model containing the number of prenatal visits and the history of hearing loss in the family was significant [χ2(2) =34.271; p<0.001]. The number of prenatal visits (OR = 2.343; 95% CI = 1.626 - 3.376) and family history of hearing loss (OR = 2.167; 95% CI = 1.507 - 3.115) were significant predictors. The other predictors were not significant. Conclusion The results reveal that newborns whose mothers had ≤ 5 prenatal visits and those with a family history of hearing loss increased their likelihood of loss to follow-up by 2.3 and 2.1 times, respectively. It is important to provide subsidies for public health improvements in order to help advise, guide and educate mothers, especially during prenatal care.


RESUMO Objetivo Analisar preditores maternos e infantis associados a perda de seguimento do programa de triagem auditiva neonatal em maternidades em maternidades do nordeste do Brasil. Método Estudo de coorte retrospectivo, incluindo dados secundários de lactentes (n=604) que foram encaminhados para o monitoramento e/ou diagnóstico do programa de triagem auditiva neonatal, em duas maternidades do nordeste do Brasil. Preditores avaliados incluíram fatores socioeconômicos, como, idade materna, estado civil, renda, escolaridade, local de residência, número de filhos e número de pré-natais; E fatores de saúde materno e infantil, como, fumo e drogas durante a gestação, consanguinidade, infecções congênitas, malformações craniofaciais, uso de drogas ototóxicas, síndromes e história de perda auditiva na família. Foi realizado análise estatística baseada em modelos de regressão logística binária, método stepwise. Resultados O modelo de regressão logística contendo o número de pré-natais e a história de perda auditiva na família foi significativo [χ2(2) =34,271; p<0,001]. Foram preditores significativos, o número de pré-natais (OR = 2,343; IC 95%= 1,626 - 3,376) e a história de perda auditiva na família (OR =2,167; IC 95% = 1,507 - 3,115), os demais preditores, não apresentaram significância neste estudo. Conclusão Os resultados demonstram que estão associados e aumentam as chances de perda de seguimento do programa, recém-nascidos cuja mães realizaram ≤ 5 pré-natais com 2,3 vezes mais chances e história de perda auditiva na família aumentando os riscos em 2,1 vezes a mais. É importante fornecer subsídios para que sejam implementadas melhorias na saúde pública que visem aconselhar, orientar e conscientizar as mães, principalmente durante os pré-natais.

9.
Audiol., Commun. res ; 28: e2657, 2023. tab, graf
Article in Portuguese | LILACS | ID: biblio-1420259

ABSTRACT

RESUMO Objetivo Estudar o processo de diagnóstico audiológico de lactentes que falharam na Triagem Auditiva Neonatal Universal (TANU). Métodos Análise dos prontuários de 51 lactentes que falharam na TANU nas maternidades do munícipio e que foram encaminhados a um centro de referência em saúde auditiva para diagnóstico audiológico, entre janeiro e junho de 2021. Foram identificados os lactentes que finalizaram o diagnóstico, aqueles que não compareceram ao agendamento para exames ou evadiram durante o processo. Tentativas de contato foram realizadas com os responsáveis pelos lactentes que evadiram, para identificar o motivo da evasão. Resultados O comparecimento ao diagnóstico ficou em 75%, com evasões entre o encaminhamento da maternidade para o centro de referência, bem como durante o processo de diagnóstico. Cinquenta por cento dos sujeitos concluíram as avaliações audiológicas até os 3 meses de vida. A tentativa de contato foi bem-sucedida com os responsáveis pelos lactentes que evadiram, sendo os motivos mais frequentes: adoecimento do lactente, distância entre a moradia e o centro de referência, horário de trabalho dos pais. Conclusão Na etapa de diagnóstico, o índice de comparecimento e o tempo de conclusão até o terceiro mês de vida da criança ficaram abaixo dos índices recomendados, diminuindo a efetividade do Programa de Triagem Auditiva Neonatal Universal (PTANU). A busca ativa por contato telefônico e uso de aplicativo de mensagem telefônico foi importante para reduzir a evasão em 76%. Outras ferramentas que aprimorem o processo para um diagnóstico não prolongado, evitando evasões, necessitam ser estudadas.


ABSTRACT Purpose To study the process of hearing assessment in infants who were referred by professionals responsible for Universal Newborn Hearing Screening (UNHS). Methods Analysis of the medical records of 51 infants referred by maternity hospitals where UNHS was performed and were referred to a Hearing Health Center, between January and June 2021. Infants who completed hearing assessment, who never attended the appointments, or were lost during the diagnostic process were identified. Attempts were made to contact infants' guardians in order to understand the reason for missing the appointments. Results The attendance to the diagnosis was 75%. Fifty percent of the infants completed hearing assessment as recommended, up to 3 months of life. The attempt to contact parents who missed the appointments was successful, and the most frequent reasons are: the infant was ill on the day of scheduled appointment, distance from home to the hearing health center, parents' working hours. Conclusion For the diagnostic stage, the attendance rate and the age for completing hearing assessment were below the recommended. The active search for telephone contact and use of phone messaging application was important to reduce evasion by seventy-six percent. Tools that optimize the diagnostic process with less infants missing still must be studied.


Subject(s)
Humans , Infant, Newborn , Infant , Neonatal Screening , Diagnostic Errors , Lost to Follow-Up , Hearing Loss/diagnosis , Evoked Potentials, Auditory, Brain Stem
10.
Rev. bras. ginecol. obstet ; Rev. bras. ginecol. obstet;45(11): 661-675, 2023. tab, graf
Article in English | LILACS | ID: biblio-1529890

ABSTRACT

Abstract Objective To assess the loss to follow-up after emergency care and during 6-months of outpatient follow-up, and the associated variables, among adolescent sexual violence survivors. Methods This is a retrospective study with review of the medical records of 521 females, aged 10 to 18 years, who received emergency care in a referral service in São Paulo, Brazil. The variables were sociodemographic; personal history; characteristics of abuse, disclosure, and reactions triggered after abuse (physical and mental disorders as well as social changes), psychotropic prescription needs, and moment of abandonment: after emergency care and before completing 6 months of outpatient follow-up. To compare groups of patients lost to follow-up at each time point, we used the Chi-square and Fisher exact tests followed by multiple logistic regression with stepwise criterion for selection of associated variables. We calculated the odds ratio with confidence interval (OR, CI 95%). The level of significance adopted was 5%. Results A total of 249/521 (47.7%) adolescents discontinued follow-up, 184 (35.3%) after emergency care and 65 (12.4%) before completing outpatient follow-up. The variables of living with a partner (OR = 5.94 [CI 95%; 2.49-14.20]); not having a religion (OR = 2.38 [CI 95%;1.29-4.38)]), having a Catholic religion [OR = 2.11 (CI 95%; 1.17-3.78)]; and not disclosing the abuse [OR = 2.07 (CI 95%; 1.25-3.44)] were associated with loss to follow-up after emergency care. Not needing mental disorder care (OR = 2.72 [CI 95%; 1.36-5.46]) or social support (OR = 2.33 [CI 95%; 1.09-4.99]) were directly associated with loss to outpatient follow-up. Conclusion Measures to improve adherence to follow-up should be aimed at adolescents who live with a partner and those who do not tell anyone about the violence.


Resumo Objetivos Avaliar a perda de seguimento de adolescentes vítimas de violência sexual após o atendimento de emergência, durante o seguimento ambulatorial e as variáveis associadas. Métodos Estudo retrospectivo com a revisão de prontuários de 521 mulheres de 10 a 18 anos, que buscaram atendimento de emergência em um serviço de referência em São Paulo, Brasil. As variáveis foram sociodemográficas; antecedentes pessoais; características do abuso, atitude de revelação e reações desencadeadas após o abuso (distúrbios físicos, mentais e mudanças sociais), necessidades de prescrição de psicotrópicos e momento do abandono: após atendimento de emergência e antes de completar 6 meses de seguimento ambulatorial. Para comparar os grupos de perda de seguimento em cada momento, foram utilizados os testes do qui-quadrado e exato de Fisher, seguidos de regressão logística múltipla com critério stepwise para seleção das variáveis associadas. Calculamos a razão de probabilidade com intervalo de confiança (RP, IC 95%). O nível de significância adotado foi de 5%. Resultados Um total de 249 (47,7%) das adolescentes descontinuaram o acompanhamento, 184 (35.3%) após o atendimento de emergência e 65 (12.4%) antes de completar o seguimento ambulatorial. As variáveis de viver com companheiro [RP = 5,94 (IC 95%; 2,49-14,20]; não ter religião [RP = 2,38 (IC 95%;1,29-4,38)], ter religião católica [RP = 2,11 (IC 95%; 1,17-3,78)] e não revelar o abuso [RP = 2,07 (IC 95%; 1,25-3,44)] foram associadas à perda de seguimento após o atendimento de emergência. Não necessitar de cuidados de saúde mental (RP = 2,72 [IC 95%; 1,36-5,46]) ou apoio social (RP = 2,33 [IC 95%; 1,09-4,99]) foram as variáveis associadas à perda do seguimento ambulatorial. Conclusão Medidas para melhorar a adesão ao seguimento devem ser direcionadas às adolescentes que vivem com parceiro e às que não revelam a violência sofrida.


Subject(s)
Humans , Female , Adolescent , Rape , Sex Offenses , Retrospective Studies , Lost to Follow-Up
11.
Porto Alegre; s.n; 2021. 70 f..
Thesis in Portuguese | LILACS | ID: biblio-1437781

ABSTRACT

Introdução: Apesar das condutas disponíveis para evitar a transmissão vertical do HIV, existem cenários como Porto Alegre, que permanecem com elevadas taxas. Perda de seguimento é aquela criança que foi exposta ao HIV, e que no momento do encerramento do caso, não foi localizada na rede de saúde para a realização de diagnóstico laboratorial. Objetivo: Analisar as "perdas de seguimentos" de crianças expostas à transmissão vertical do HIV e os fatores associados, no município de Porto Alegre. Métodos: Trata-se de um estudo de coorte histórica, no período de 2000 a 2017. Os dados foram coletados do Sistema de Informação de Agravos de Notificação. Foram investigadas informações relativas à mãe e a criança. Comparações foram realizadas por meio do teste de homogeneidade de proporções baseado na estatística de qui-quadrado de Pearson. Preditores foram investigados por modelo de regressão de Poisson com variação robusta. Resultados: Entre as 8.520 crianças expostas ao HIV, 1.762 (25,9%) foram classificadas como perda de seguimento. O perfil demográfico das mães de crianças perda de seguimento é de mulheres entre 21 a 35 anos (71,1%), predominantemente com 4 a 7 anos de estudo (49,9%), e brancas (53,9%). Em 78,4% dos casos o pré-natal não foi iniciado no primeiro trimestre (p<0,001). Estiveram associados à perda de seguimento os seguintes fatores socioeconômicos, comportamentais e de saúde das gestantes: ter até 20 anos de idade (OR = 1,47, IC95%: 1,17-1,84) ou 21 a 35 anos (OR = 1,34, IC95%: 1,09-1,64); se autodeclarar como preta (OR = 1,11, IC95% 1,01-1,24); fazer uso de drogas injetáveis (OR = 1,21, IC95%: 1,04-1,42), diagnóstico de HIV durante o pré-natal ou parto (OR = 1,32, IC95%: 1,19-1,47), e iniciar o pré-natal após o primeiro trimestre (OR = 1,22, IC95%: 1,08-1,39). Conclusão: Um expressivo percentual de gestante apresentou início tardio de pré-natal. Os preditores da perda de seguimento, que foram: idade mais jovem, autodeclarar raça/cor preta, uso de drogas injetáveis, diagnóstico de HIV no pré-natal ou parto e início tardio do pré-natal, remetem aos contextos de vulnerabilidade individual, social e programático que as gestantes estão inseridas.


Introduction: Despite the available conducts to prevent mother-to-child transmission of HIV, there are scenarios, such as Porto Alegre, that remain with high rates. Loss to follow-up is a child exposed to HIV who, at the time of case closure, was not located in the health network for laboratory diagnosis. Objective: To analyze the "loss to follow-up" of children exposed to mother-to-child transmission of HIV and the associated factors in the municipality of Porto Alegre. Methods: This is a historical cohort study from 2000 to 2017. Data were collected from the Notifiable Diseases Information System. Information regarding the mother and the child were investigated. Comparisons were made using the homogeneity of proportions test based on Pearson's chi-square statistic. Predictors were investigated using the Poisson's regression model with robust variation. Results: Among the 8,520 children exposed to HIV, 1,762 (25.9%) were classified as loss to follow-up. The demographic profile of mothers of children lost to follow-up is of women aged 21 to 35 years (71.1%), predominantly with 4 to 7 years of education (49.9%), and white (53.9%). In 78.4% of the cases, prenatal care was not started in the first trimester (p<0.001). The following socioeconomic, behavioral, and health factors were associated with loss to follow-up: being up to 20 years old (aRR 1.47; 95% CI 1,17-1,84) or 21 to 35 years old (aRR 1.34; 95% CI 1,09-1,64); self-reporting as black (aRR 1.11; 95% CI 1,01-1,24); using injective drugs (aRR 1.21; 95% CI 1,04-1,42); HIV diagnosis during prenatal care or childbirth (aRR 1.32; 95% CI 1,19-1,47); and late entry into prenatal care (aRR 1.22; 95% CI 1,08-1,39). Conclusion: A significant percentage of pregnant women had delayed prenatal care. The predictors of loss to follow-up, which were: younger age, self-reporting black race/color, use of injectable drugs, HIV diagnosis during prenatal care or childbirth, and late initiation of prenatal care, refer to the contexts of individual, social, and programmatic vulnerability in which pregnant women are inserted.


Subject(s)
Public Health
12.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;54(4): e10370, 2021. tab, graf
Article in English | LILACS | ID: biblio-1153538

ABSTRACT

This study aimed to investigate the effect of WeChat-based education and rehabilitation program (WERP) on anxiety, depression, health-related quality of life (HRQoL), major adverse cardiac/cerebrovascular events (MACCE)-free survival, and loss to follow-up rate in unprotected left main coronary artery disease (ULMCAD) patients after coronary artery bypass grafting (CABG). In this randomized controlled study, 140 ULMCAD patients who underwent CABG were randomly assigned to WERP group (n=70) or control care (CC) group (n=70). During the 12-month intervention period, anxiety and depression (using hospital anxiety and depression scale (HADS)) and HRQoL (using 12-Item Short-Form Health Survey (SF-12)) were assessed longitudinally. During the total 36-month follow-up period (12-month intervention and 24-month non-intervention periods), MACCE and loss to follow-up were recorded. During the intervention period, HADS-anxiety score at month 9 (M9) (P=0.047) and month 12 (M12) (P=0.034), anxiety rate at M12 (P=0.028), and HADS-D score at M12 (P=0.048) were all reduced in WERP group compared with CC group. As for HRQoL, SF-12 physical component summary score at M9 (P=0.020) and M12 (P=0.010) and SF-12 mental component summary score at M9 (P=0.040) and M12 (P=0.028) were all increased in WERP group compared with CC group. During the total follow-up period, WERP group displayed a trend of longer MACCE-free survival than that in CC group but without statistical significance (P=0.195). Additionally, loss to follow-up rate was attenuated in WERP group compared with CC group (P=0.033). WERP serves as an effective approach in optimizing mental health care and promoting life quality in ULMCAD patients after CABG.


Subject(s)
Humans , Quality of Life , Coronary Artery Disease/surgery , Anxiety/prevention & control , Coronary Artery Bypass , Follow-Up Studies , Depression/prevention & control
13.
Bol. malariol. salud ambient ; 61(2): 224-231, 2021. tab, graf
Article in Spanish | LILACS, LIVECS | ID: biblio-1411708

ABSTRACT

Los diversos fármacos para luchar contra el complejo Mycobacterium tuberculosis, causante de la tuberculosis, han sido utilizados por varias décadas, resultando de manera colateral en la mutación de cepas resistentes a uno o más de esos medicamentos. La tuberculosis multirresistente, identificada como TB-MDR, es una forma de tuberculosis causada por bacterias que no responden a la isoniazida y la rifampicina, los fármacos de primera línea más eficaces. La Organización Mundial de la Salud (OMS) describe dos esquemas de tratamiento con medicamentos de segunda línea para estos pacientes: el tradicional esquema alargado, y el más reciente esquema corto, que varían en duración y en los medicamentos administrados. Aquellos casos donde los pacientes que no finalizan su tratamiento se denominan Pérdida Del Seguimiento (PDS), aumentando los riesgos para el paciente y para la comunidad. En esta investigación se desarrolla un modelo predictivo, basándose en los datos del tratamiento de 3 grupos de pacientes con tuberculosis farmacorresistente en Ecuador entre los años 2010 y 2015, el cual permite concluir que la aplicación del régimen corto de tratamiento posibilita reducir a casi la mitad el número de pacientes que interrumpen su asistencia al programa, en comparación al régimen largo de 2 años, aunado a que factores como los desafíos psicológicos, las dificulades financieras o los efectos secundarios de los medicamentos pueden tener menor impacto en el paciente que es tratado en menor tiempo(AU)


Diverse drugs to fight the Mycobacterium tuberculosis complex, which causes tuberculosis, have been used for several decades, collaterally resulting in the mutation of strains resistant to one or more of these drugs. Multi-drug resistant tuberculosis, identified as MDR-TB, is a form of tuberculosis caused by bacteria that do not respond to isoniazid and rifampin, the most effective first-line drugs. The World Health Organization (WHO) describes two treatment schemes with second-line drugs for these patients: the traditional long scheme, and the more recent short scheme, which vary in duration and in the drugs administered. Those cases where patients who do not finish their treatment are called Loss Of Follow-up, increasing the risks for the patient and the community. In this research, a predictive model is developed, based on data from the treatment of 3 groups of patients with drug-resistant tuberculosis in Ecuador between 2010 and 2015, which allows to conclude that the application of the short treatment regimen makes it possible to reduce by almost half the number of patients who interrupt their attendance to the program, compared to the long regimen of 2 years, joined factors such as psychological challenges, financial difficulties or side effects of medications may have less impact on the patient who is treated in less time(AU)


Subject(s)
Humans , Male , Female , Tuberculosis , Drug Resistance
14.
Int J Med Inform ; 141: 104198, 2020 09.
Article in English | MEDLINE | ID: mdl-32574924

ABSTRACT

BACKGROUND: Tuberculosis is the leading cause of infectious disease-related death, surpassing even the immunodeficiency virus. Treatment loss to follow up and irregular medication use contribute to persistent morbidity and mortality. This increases bacillus drug resistance and has a negative impact on disease control. OBJECTIVE: This study aims to develop a computational model that predicts the loss to follow up treatment in tuberculosis patients, thereby increasing treatment adherence and cure, reducing efforts regarding treatment relapses and decreasing disease spread. METHODS: This is a case-controlled study. Included in the data set were 103,846 tuberculosis cases from the state of São Paulo. They were collected using the TBWEB, an information system used as a tuberculosis treatment monitor, containing samples from 2006 to 2016. This set was later resampled into 6 segments with a 1-1 ratio. This ratio was used to avoid any bias during the model construction. RESULTS: The Classification and Regression Trees were used as the prediction model. Training and test sets accounted for 70% in the former and 30% in the latter of the tuberculosis cases. The model displayed an accuracy of 0.76, F-measure of 0.77, sensitivity of 0.80 and specificity of 0.71. The model emphasizes the relationship between several variables that had been identified in previous studies as related to patient cure or loss to follow up treatment in tuberculosis patients. CONCLUSION: It was possible to construct a predictive model for loss to follow up treatment in tuberculosis patients using Classification and Regression Trees. Although the fact that the ideal predictive ability was not achieved, it seems reasonable to propose the use of Classification and Regression Trees models to predict likelihood of treatment follow up to support healthcare professionals in minimising the loss to follow up.


Subject(s)
Tuberculosis , Brazil/epidemiology , Case-Control Studies , Follow-Up Studies , Humans , Tuberculosis/drug therapy , Tuberculosis/epidemiology
15.
J. bras. pneumol ; J. bras. pneumol;45(2): e20180167, 2019. tab, graf
Article in English | LILACS | ID: biblio-1002438

ABSTRACT

ABSTRACT Objective: To evaluate the treatment compliance of patients with paracoccidioidomycosis. Methods: We studied 188 patients with paracoccidioidomycosis admitted to a tertiary referral hospital in the Central-West Region of Brazil from 2000 to 2010, to assess their compliance to treatment. In order to be considered compliant, patients needed to present two established criteria: (1) receive medicines from the pharmacy, and (2) achieve a self-reported utilization of at least 80% of the dispensed antifungal compounds prescribed since their previous appointment. Results: Most patients were male (95.7%), had the chronic form of the disease (94.2%), and were treated with cotrimoxazole (86.2%). Only 44.6% of patients were treatment compliant. The highest loss to follow-up was observed in the first 4 months of treatment (p < 0.02). Treatment compliance was higher for patients with than for those without pulmonary involvement (OR: 2.986; 95%CI 1.351-6.599), and higher for patients with than without tuberculosis as co-morbidity (OR: 2.763; 95%CI 1.004-7.604). Conclusions: Compliance to paracoccidioidomycosis treatment was low, and the period with the highest loss to follow-up corresponds to the first four months. Pulmonary paracoccidioidal involvement or tuberculosis comorbidity predicts a higher compliance to paracoccidioidomycosis therapy.


RESUMO Objetivo: Avaliar a adesão ao tratamento de paracoccidioidomicose. Métodos: Estudo conduzido com 188 pacientes com paracoccidioidomicose atendidos em um hospital terciário na Região Centro-Oeste do Brasil, de 2000 a 2010, para avaliar adesão ao tratamento. Foram considerados aderentes pacientes que tiveram o seguinte critério: retiraram os medicamentos na farmácia e autorrelataram a utilização de, no mínimo, 80% de dispensação dos antifúngicos prescritos na última consulta. Resultados: A maioria dos pacientes era homem (95,7%), tinha a forma crônica da doença (94,2%) e foi tratada com sulfametoxazol/trimetropim (86,2%). Apenas 44,6% dos pacientes aderiram ao tratamento. A maior perda de seguimento foi observada nos primeiros 4 meses de tratamento (p < 0,02). Adesão ao tratamento foi maior em pacientes com do que sem envolvimento pulmonar (RC: 2,986; IC95% 1,351-6,6599) e maior para os pacientes com do que sem tuberculose associada (RC 2,763; IC95% 1,004-7,604). Conclusões: A adesão ao tratamento da paracoccidioidomicose foi baixa e os primeiros 4 meses constituíram o período com maior evasão. Pacientes com envolvimento paracocidióidico pulmonar ou tuberculose associada revelaram maior adesão ao tratamento da paracoccidioidomicose.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Paracoccidioidomycosis/drug therapy , Medication Adherence/statistics & numerical data , Antifungal Agents/therapeutic use , Time Factors , Brazil , Prospective Studies , Follow-Up Studies , Treatment Outcome
16.
J Int Assoc Provid AIDS Care ; 16(6): 523-526, 2017.
Article in English | MEDLINE | ID: mdl-29187075

ABSTRACT

In September 2015, the World Health Organization updated their guidelines to recommend antiretroviral therapy (ART) for all people living with HIV. Countries are now in the process of implementing strategies to provide universal HIV treatment. We analyzed the rate of retention and time to ART eligibility (according to 2013 WHO guidelines) among 3,345 adult patients receiving positive HIV test results between February 1, 2003 and March 31, 2013 at the GHESKIO Clinic in Haiti, with WHO stage 1 or 2 disease and initial CD4 cell count >500 cells/mm3. Among the 3,345 patients, 2,423 (72%) were female, the median age was 33 years, 3,089 (92%) lived in Port-au-Prince, and 1,944 (58%) had attended no school or primary school only. The median initial CD4 cell count was 668 cells/mm3 (IQR: 572-834); over the subsequent 2 years, 1,485 patients (44%) were lost to follow-up and 7 (<1%) died pre-ART, 1,041 (31%) were retained in pre-ART care, and 819 (24%) initiated ART. In multivariate analysis, secondary education (aOR 1.27; 95% CI: 1.10-1.47), female gender (aOR: 1.28; 95% CI: 1.09-1.50), co-habitation (aOR: 1.31; 95% CI: 1.09-1.57), and residence in Port-au-Prince (aOR: 1.43; 95% CI: 1.09-1.88) were associated with retention in care. The median time from baseline CD4 count to ART eligibility was 1.7 years. Prior to the implementation of universal treatment, pre-ART attrition was high among patients who did not qualify for ART at presentation. Though implementing WHO recommendations for universal ART will require service expansion, it will likely result in improved retention for those at risk of being lost to follow-up.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Lost to Follow-Up , Adult , CD4 Lymphocyte Count , Educational Status , Female , Haiti , Humans , Kaplan-Meier Estimate , Male , Multivariate Analysis , Proportional Hazards Models , Residence Characteristics/statistics & numerical data , Risk Factors , Sex Factors , Time Factors , World Health Organization
17.
J Pediatr ; 188: 210-216.e1, 2017 09.
Article in English | MEDLINE | ID: mdl-28606372

ABSTRACT

OBJECTIVE: To assess mortality and loss to follow-up of children with HIV infection who started antiretroviral therapy (ART) through the Universal Coverage Health Program (UC) in Thailand. STUDY DESIGN: Children with HIV infection who initiated ART at age <15 years through the UC between 2008 and 2013 were included in the analysis. Death was ascertained through linkage with the National Death Registry. A competing-risks method was used to calculate subdistribution hazard ratios (SHRs) of predictors for loss to follow-up. Death was considered a competing risk. Cox proportional hazards models were used to assess predictors of mortality. RESULTS: A total of 4618 children from 497 hospitals in Thailand were included in the study. Median age at ART initiation was 9 years (IQR, 6-12 years), and the median duration of tracking was 4.1 years (a total of 18 817 person-years). Three hundred and ninety-five children (9%) died, for a mortality rate of 2.1 (95% CI, 1.9-2.3) per 100 person-years, and 525 children (11%) were lost to follow-up, for a lost to follow-up rate of 2.9 (95% CI, 2.7-3.2) per 100 person-years. The cumulative incidence of loss to follow-up increased from 4% at 1 year to 8.8% at 3 years. Children who started ART at age ≥12 years were at the greatest risk of loss to follow-up. The probability of death was 3.2% at 6 months and 6.4% at 3 years. Age ≥12 years at ART initiation, lower baseline CD4%, advanced HIV staging, and loss to follow-up were associated with mortality. CONCLUSION: The Thai national HIV treatment program has been very effective in treating children with HIV infection, with low mortality and modest rates of loss to follow-up.


Subject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/drug therapy , HIV Infections/mortality , Lost to Follow-Up , Adolescent , CD4 Lymphocyte Count , Child , Child, Preschool , Female , Humans , Male , Proportional Hazards Models , Thailand , Universal Health Insurance
18.
J Int AIDS Soc ; 20(Suppl 3): 21475, 2017 05 16.
Article in English | MEDLINE | ID: mdl-28530040

ABSTRACT

INTRODUCTION: The HIV epidemics in the Caribbean, Central America and South America (CCASA), Eastern Europe (EE) and Asia and Pacific (AP) regions are diverse epidemics affecting different key populations in predominantly middle-income countries. This narrative review describes the populations of HIV-positive youth approaching adolescence and adulthood in CCASA, EE and AP, what is known of their outcomes in paediatric and adult care to date, ongoing research efforts and future research priorities. METHODS: We searched PubMed and abstracts from recent conferences and workshops using keywords including HIV, transition and adolescents, to identify published data on transition outcomes in CCASA, EE and AP. We also searched within our regional clinical/research networks for work conducted in this area and presented at local or national meetings. To give insight into future research priorities, we describe published data on characteristics and health status of young people as they approach age of transition, as a key determinant of health in early adulthood, and information available on current transition processes. RESULTS AND DISCUSSION: The perinatally HIV-infected populations in these three regions face a range of challenges including parental death and loss of family support; HIV-related stigma and socio-economic disparities; exposure to maternal injecting drug use; and late disclosure of HIV status. Behaviourally HIV-infected youth often belong to marginalized sub-groups, with particular challenges accessing services and care. Differences between and within countries in characteristics of HIV-positive youth and models of care need to be considered in comparisons of outcomes in young adulthood. The very little data published to date on transition outcomes across these three regions highlight some emerging issues around adherence, virological failure and loss to follow-up, alongside examples of programmes which have successfully supported adolescents to remain engaged with services and virologically suppressed. CONCLUSIONS: Limited data available indicate uneven outcomes in paediatric services and some shared challenges for adolescent transition including retention in care and adherence. The impact of issues specific to low prevalence, concentrated epidemic settings are poorly understood to date. Outcome data are urgently needed to guide management strategies and advocate for service provision in these regions.


Subject(s)
HIV Infections , Transition to Adult Care , Adolescent , Adult , Biomedical Research , Caribbean Region/epidemiology , Central America/epidemiology , Child , Epidemics , Europe, Eastern/epidemiology , Female , HIV Infections/epidemiology , Health Status , Humans , Male , Social Stigma , South America/epidemiology , Young Adult
19.
Rev. colomb. cancerol ; 21(1): 19-25, ene.-mar. 2017. tab, graf
Article in Spanish | LILACS | ID: biblio-900449

ABSTRACT

Resumen Objetivo: Determinar la adherencia al seguimiento y la evolución de las lesiones en mujeres con diagnóstico de NIC 1. Metodología: Fueron seleccionadas mujeres no embarazadas, mayores de 18 años de edad, remitidas a colposcopia, sin antecedentes de NIC, histerectomía previa o terapia ablativa en el cuello uterino, que obtuvieron diagnóstico por biopsia de NIC 1 y fueron sometidas a manejo expectante. Se les aplicó un cuestionario de factores de riesgo y se documentó el resultado de la citología previa a colposcopia. El seguimiento consistió en examen citológico y colposcópico cada 6 meses durante 1 año. Se consideraron no adherentes aquellas que a los 15 meses no contaron con evaluaciones (citología y colposcopia / colposcopia) o tratamientos documentados. Resultados: Se incluyó a 40 mujeres, de 95 elegibles con NIC 1. La tasa de deserción fue de 17/40 (42,5%). Las variables demográficas y clínicas más frecuentemente asociadas a no-adherencia a seguimiento fueron la nuliparidad y el inicio temprano de las relaciones sexuales. La evolución de lesión de bajo grado a alto grado pudo observarse en el 4,3% y el abandono del manejo conservador a terapia invasiva fue 22,5%. Conclusión: Hubo una alta tasa de pérdida de seguimiento y deserción del manejo conservador hacia terapia invasiva. Un gran porcentaje de pacientes sufrió regresión de la NIC 1. El estudio ayudará a aclarar las estrategias óptimas para el manejo de las anormalidades cervicales de bajo grado en poblaciones con bajas condiciones socioculturales.


Abstract Objective: To determine adherence to follow-up and outcome of lesions in women diagnosed with grade 1 cervical intraepithelial neoplasia (CIN 1). Methodology: The study included non-pregnant women aged 18 or older, referred for col poscopy, with a colposcopy directed biopsy diagnosis of CIN 1, with no history of prior CIN, hysterectomy or cervical ablative therapy. Participants answered a questionnaire on risk fac tors, and the outcome of previous cytology and colposcopy was documented. All women should have been followed up for 1 year with cytology and colposcopy every six months. Those who did not have cytology and colposcopy / colposcopy assessments or documented treatments after 15 months were considered as non-adherent. Results: A total of 40 patients with CIN 1 were included. The loss to follow-up rate of loss was 17/40 (42.5%). The demographic and clinical variables most frequently associated with non-adherence to follow-up were null parity and early initiation of sexual intercourse. The progression of low-grade to high-grade lesion was observed in 4.3%. 22.5% failed Conservative treatment failed conservative treatment and moved to invasive therapy. Conclusion: The rate of loss to follow-up was high, with a considerable referral from conser vative to invasive therapy. A large percentage of patients had regression of CIN 1. This study should help clarify the optimal strategies for the treatment of women with low-grade cervical abnormalities in populations of low sociocultural conditions and high risk of cervical cancer.


Subject(s)
Humans , Female , Adult , Uterine Cervical Neoplasms , Cervix Uteri , Colposcopy , Lost to Follow-Up , Therapeutics , Women , Aftercare
SELECTION OF CITATIONS
SEARCH DETAIL